1.        经颈静脉肝内门体静脉分流术关键穿刺套件研发，北京市科技计划，项目负责人，2020.09 至 2023.09，100万元

2.        金纳米颗粒涂层支架光热效应预防大鼠气道支架植入后支架相关狭窄的实验研究，国自然面上项目，项目负责人，2019.01.01 至 2022.12.31，57万元

3.        糖代谢异常在肝癌介入中的作用及治疗研究，国自然面上项目，项目负责人，2017.01.01 至 2020.12.31，58万元

4.        基于增强现实导航的肺癌介入诊治一体化关键技术研究，国家重点研发计划，项目负责人，2017.07.01 至 2019.12.31，994万元

5.        通过改变肝癌TACE手术入路提高介入治疗科病床周转率的研究，院级，项目负责人，2017.10.01 至 2019.09.30

6.        经颈静脉肝内门体分流术（TIPS）治疗肝硬化并肝癌患者门脉高压出血安全性及有效性的研究，院级，项目负责人，2015.10.01 至 2018.09.30

7.        经皮脾肾分流术治疗肝硬化门脉高压症的实验研究，国自然面上，项目负责人，2014.01.01 至 2017.12.31，70万元

8.        门静脉栓塞选择性诱导肝叶增生的实验研究，国自然面上，项目负责人，2012.01.01 至 2015.12.31，58万元

9.        动脉栓塞联合非细胞毒性药物治疗大鼠肝癌的实验研究，国自然面上，项目负责人，2008.01.01 至 2010.12.31，30万元

1.  北京市科技计划；经颈静脉肝内门体静脉分流术关键穿刺套件研发（2020.09- 2023.09），主持

2.  国家自然科学基金面上项目：金纳米颗粒涂层支架光热效应预防大鼠气道支架植入后支架相关狭窄的实验研究（2019.01.01-2022.12.31），主持

3.  国家自然科学基金面上项目：糖代谢异常在肝癌介入中的作用及治疗研究（2017.01.01-2020.12.31），主持

4.  国家重点研发计划：基于增强现实导航的肺癌介入诊治一体化关键技术研究（2017.07.01-2019.12.31），主持

5.  国家自然科学基金面上项目：经皮脾肾分流术治疗肝硬化门脉高压症的实验研究（2014.01.01-2017.12.31），主持

6.  国家自然科学基金面上项目：门静脉栓塞选择性诱导肝叶增生的实验研究（2012.01.01-2015.12.31），主持

7.  国家自然科学基金面上项目：动脉栓塞联合非细胞毒性药物治疗大鼠肝癌的实验研究（2008.01.01-2010.12.31），主持

1. Yan Fu, Tao Gong, Jiaywei Tsauo, Mingchen Sang, He Zhao, Xiaowu Zhang,Jingui Li, Xiao Li. Nintedanib, a multitarget tyrosine kinase inhibitor,suppresses postoperative peritoneal adhesion formation in a rat model. Surgery.2021 May 7;S0039-6060(21)00316-0. doi: 10.1016/j.surg.2021.03.055.

2. He Zhao, Yan Fu, Jiaywei Tsauo, Xiaowu Zhang, Yanqing Zhao, Tao Gong,Jingui Li, Xiao Li. Silver nanoparticle-coated self-expandable metallic stentsuppresses tissue hyperplasia in a rat esophageal model. Surg Endosc. 2021. doi:10.1007/s00464-020-08238-4.

3. Jingui Li, Tao Gong, Jiaywei Tsauo, He Zhao, Xiaowu Zhang, MingchenSang, Xiao Li. Fluoroscopy-Guided Gastrojejunostomy Creation withLumen-Apposing Metal Stent in a Porcine Model. Cardiovasc Intervent Radiol. 2020;43(11):1687-1694.

4. Yingen Luo, Xiaowu Zhang, Jiaywei Tsauo, Hwoon-Yong Jung, Ho-Young Song,He Zhao, Jingui Li, Tao Gong, Peng Song, Xiao Li. Intragastric satiety-inducingdevice reduces food intake and suppresses body weight gain in a rodent model. SurgEndosc. 2021;35(3):1052-1057.

5. He Zhao, Jiaywei Tsauo, Xiao-Wu Zhang, Huai-Yuan Ma, Ning-Na Weng,Gong-Shun Tang, Xiao Li. Technetium-99m-labeled macroaggregated albumin lungperfusion scan for diagnosis of hepatopulmonary syndrome: A prospective studycomparing brain uptake and whole-body uptake. World J Gastroenterol.2020;26(10):1088-1097.

6. Yanqing Zhao, Xiaowu Zhang, He Zhao, Tao Gong, Jingui Li, Jiaywei Tsauo,Xiao Li. Systemic Therapy Plus Thermal Ablation Versus Systemic Therapy Alonefor Oligometastatic Liver Metastases from Non-small Cell Lung Cancer.Cardiovasc Intervent Radiol. 2020;43(9):1285-1293.

7. Tsauo J, Zhao H, Zhang X, Ma H, Jiang M, Weng N, Li X. Changes inarterial oxygenation after portal decompression in Budd-Chiari syndromepatients with hepatopulmonary syndrome. Eur Radiol. 2019;29(6):3273-3280.

8. Tsauo J1, Zhao H1, Zhang X1, Ma H2, Jiang M2, Weng N2, Li X3. Effect of Transjugular Intrahepatic Portosystemic ShuntCreation on Pulmonary Gas Exchange in Patients with Hepatopulmonary Syndrome: AProspective Study. J Vasc Interv Radiol. 2019;30(2):170-177.

9. Yu J, Wang X, Jiang M, Ma H, Zhou Z, Yang L, Li X. Comparison oftransjugular intrahepatic portosystemic shunt (TIPS) alone and combined withembolisation for the management of cardiofundal varices: a retrospective study.Eur Radiol.2019;29(2):699-706.

10. Qiu B, Zhang X, Tsauo J, Zhao H, Gong T, Li J, Li X. Transcatheterarterial infusion for pancreatic cancer: a 10-year National Cancer Centerexperience in 115 patients and literature review. Abdom Radiol (NY).2019;44(8):2801-2808.

11. Li X, Tsauo J, Geng C, Zhao H, Lei X, Li X. Ginsenoside Rg3 DecreasesNHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1 α Pathway inHepatocellular Carcinoma: A Novel Antitumor Mechanism. Am J Chin Med.2018;46(8):1915-1931.

12. Zhao H, Tsauo J, Zhang X, Li X. Regarding "The optimal procedure ofmodified Rex shunt for the treatment of extrahepatic portal hypertension inchildren". J Vasc Surg Venous Lymphat Disord. 2018;6(3):421-422.

13. Huang X, Tsauo J, Zhao H, Li X. Re: Immuno-oncology and ItsOpportunities for Interventional Radiologists: Immune Checkpoint Inhibition andPotential Synergies with Interventional Oncology Procedures. J Vasc IntervRadiol. 2018;29(4):58.

14. Zhao H, Tsauo J, Zhang X, Ma H, Weng N, Wang L, Li X. Pulmonary transittime derived from pulmonary angiography for the diagnosis of hepatopulmonarysyndrome. Liver Int.2018;38(11):1974-1981.

15. Tao Z, Yan C, Zhao H, Tsauo J, Zhang X, Qiu B, Zhao Y, Li X. Comparisonof endoscopic ultrasonography and magnifying endoscopy for assessment of theinvasion depth of shallow gastrointestinal neoplasms: a systematic review andmeta-analysis. Surg Endosc. 2017;31(12):4923-4933.

16. Luo X, Wang X, Zhao Y, Ma H, Ye L, Yang L, Tsauo J, Jiang M, Li X.Real-Time 3D CT Image Guidance for Transjugular Intrahepatic PortosystemicShunt Creation Using Preoperative CT: A Prospective Feasibility Study of 20Patients. AJR Am J Roentgenol.2017 Jan;208(1):W11-W16.

17. Deng P, Zhou B, Li X. Risk factors contributing to early infectionfollowing transjugular intrahepatic portosystemic shunt in perioperativeperiod. Ann Hepatol. 2016 Sep-Oct;15(5):752-6.

18.Zhang X, Li X. Successful Embolization of aHuge Hepatic Artery Pseudoaneurysm after Blunt Abdominal Trauma. J Pediatr. 2016;168:252-252.e1.

19. Tsauo J, Li X. Viatorr TIPS Endoprosthesis Versus Generic ExpandedPolytetrafluoroethylene-Covered Stent-Grafts. AJR Am J Roentgenol. 2015;205(4):W463.

20. Zhao H, Tsauo J, Wang X, Li X. Accurate measurement of the normalityvalues of macroaggregated albumin lung perfusion scan in hepatopulmonarysyndrome. Ann Nucl Med. 2015t;29(8):754-5.

21. Tsauo J, Weng N, Ma H, Jiang M, Zhao H, Li X. Role of TransjugularIntrahepatic Portosystemic Shunts in the Management of HepatopulmonarySyndrome: A Systemic Literature Review. J Vasc Interv Radiol. 2015Sep;26(9):1266-71.

22. Luo X, Ye L, Zhou X, Tsauo J, Zhou B, Zhang H, Zhang X, Li X. C-ArmCone-Beam Volume CT in Transjugular Intrahepatic Portosystemic Shunt: InitialClinical Experience. Cardiovasc Intervent Radiol. 2015;38(6):1627-31.

23. Tsauo J1, Li X1. Portal vein aneurysm associated with Budd-Chiarisyndrome treated with transjugular intrahepatic portosystemic shunt: a casereport. World J Gastroenterol. 2015;21(9):2858-61.

24. Wang Z, Zhao H, Wang X, Zhang H, Jiang M, Tsauo J, Luo X, Yang L, Li X.Clinical outcome comparison between TIPS and EBL in patients with cirrhosis andportal vein thrombosis. Abdom Imaging. 2015;40(6):1813-20.

25. Jiang M, Wang Z, Tsauo J, Li X. Basal ganglia hyperintensity may be amarker of hepatic encephalopathy secondary to portosystemic shunting. ClinRes Hepatol Gastroenterol. 2015;39(1):e5-6.

26. Zhou Y, Tsauo J, Li Y, Li X. Selective Embolization of SystemicCollaterals for the Treatment of Recurrent Hemoptysis Secondary to theUnilateral Absence of a Pulmonary Artery in a Child. Cardiovasc InterventRadiol. 2015;38(5):1312-5.

27. Tsauo J, Luo X, Ye L, Li X. Three-dimensional path planningsoftware-assisted transjugular intrahepatic portosystemic shunt: a technicalmodification. Cardiovasc Intervent Radiol. 2015;38(3):742-6.

28. Zhao H, Tsauo J, Ma HY, Li X. The role ofmacroaggregated albumin lung perfusion scan in hepatopulmonary syndrome: are weready to draw conclusions? Liver Int.2015;35(7):1918-9.

29. Chen 1, Wang W, Tam MD, Quintini C, Fung JJ,Li X. Transjugular intrahepatic portosystemic shunt inliver transplant recipients: indications, feasibility, and outcomes. Hepatol Int. 2015;9(3):391-8.

30. Luo X, Wang Z, Tsauo J, Zhou B, Zhang H, Li X.  Advanced Cirrhosis Combined with Portal VeinThrombosis:  A Randomized Trial of TIPSversus EndoscopicBand Ligation Plus Propranolol for the Prevention of RecurrentEsophageal Variceal Bleeding. Radiology. 2015; 276(1):286-93.

31. Luo X, Wang Z, Tsauo J, Zhou B, Zhang H, Li X. AdvancedCirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPSversus Endoscopic Band Ligation Plus Propranolol for the Prevention ofRecurrent Esophageal Variceal Bleeding.Radiology.2015 Jul;276(1):286-93.

32. Luo X, Nie L, Zhou B, Yao D, Ma H, Jiang M, Zhang H, Li X. Transjugularintrahepatic portosystemic shunt for the treatment of portal hypertension innoncirrhotic patients with portal cavernoma. Gastroenterol Res Pract.2014;2014:659726. doi: 10.1155/2014/659726.

33. Wang Z, Zhang H, Zhao H, Wang X, Tsauo J, Luo X, Li X. Repeated transcatheterarterial chemoembolization is safe for hepatocellular carcinoma in cirrhoticpatients with transjugular intrahepatic portosystemic shunt.DiagnInterv Radiol.2014;20(6):487-91.

34. Jiang M, Wang Z, Tsauo J, Li X. Basal ganglia hyperintensity may be amarker of hepatic encephalopathy secondary to portosystemic shunting. Clin ResHepatol Gastroenterol. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):e5-6.

35. Zhou Y, Tsauo J, Li Y, Li X. Selective Embolization of SystemicCollaterals for the Treatment of Recurrent Hemoptysis Secondary to theUnilateral Absence of a Pulmonary Artery in a Child. Cardiovasc InterventRadiol. 2015 Oct;38(5):1312-5.

36. Tsauo J, Yu Y, Luo X, Wang Z, Liu L, Li X. Direct intrahepaticportocaval shunt creation via the inter-strut space of the inferior vena cavastent. Clin Radiol. 2014 Sep;69(9):896-9.

37. Yu Y, Zhang C, Liu L, Li X. Hepatic arterial administration ofginsenoside Rg3 and transcatheter arterial embolization for the treatment ofVX2 liver carcinomas. ExpTher Med 2013;5:761-766.

38. TsauoJ, Yang D, Ma H, Li X. TraumaticInferior Gluteal Artery Pseudoaneurysm with Compressive Neuropathy Managed withEndovascular Embolization and Surgery. Cardiovasc Intervent Radiol.2014;37(1):275-7.

39. Tsauo J, Liu L, Li X. Hepatobiliary and pancreatic: transient hepaticischemia caused by acute portal vein thrombosis. J Gastroenterol Hepatol. 2013;28(9):1433.

40. Tsauo J, Liu L, Tang C, Li X. Education and Imaging. Hepatobiliaryand pancreatic: spontaneous intrahepatic portosystemic shunt associated withcirrhosis. J Gastroenterol Hepatol. 2013;28(6):904.

41. Tsauo J, Liu L, Li X. Hepatobiliary and pancreatic:transient hepatic ischemia caused by acute portal vein thrombosis. JGastroenterol Hepatol. 2013;28:1433.

42. Tsauo J, Li X, Li H, Wei B, Luo X, Zhang C, TangC. Transjugular insertion of bare-metal biliary stent for the treatment ofdistal malignant obstructive jaundice complicated by coagulopathy. Cardiovasc InterventRadiol. 2013;36:521-525.

43. Luo XF, Nie L, Wang Z,Tsauo J, Liu LJ, Yu Y, Zhou B, Li X.Stent-grafts for the treatment of TIPS dysfunction: fluency stent vs Wall graftstent. World J Gastroenterol. 2013;19:5000-5005.

44. Luo X, Nie L, Wang Z, Tsauo J, Tang C, Li X. Transjugular EndovascularRecanalization of Splenic Vein in Patients with Regional Portal Hypertension Complicatedby Gastrointestinal Bleeding. Cardiovasc Intervent Radiol. 2014Feb;37(1):108-13.

45. Luo X, Nie L, Tsauo J,Wang Z, Tang C, Li X. Parallel shuntfor the treatment of transjugular intrahepatic portosystemic shunt dysfunction.Korean J Radiol 2013;14:423-429.

46. Chen S, Li X, Wei B, Tong H, Zhang MG, HuangZY, Cao JW. Recurrent variceal bleeding and shunt patency: prospectiverandomized controlled trial of transjugular intrahepatic portosystemic shuntalone or combined with coronary vein embolization. Radiology 2013;268:900-906.

47. Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Antitumor effects ofginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep2012;5:1295-1298.

48. Wang Z, Yu Y, Yang W, Chen B, Li X. Does Helicobacter pylori eradicationreally reduce the risk of gastric cancer at the population level? Gut. 2013Jun;62(6):950.

49. Nie L, Luo XF, Li X. Gastrointestinal bleeding caused by extrahepatic arterioportalfistula associated with portal vein thrombosis. World J Gastroenterol 2012;18:6501-6503.

50. Liu L, Yu Y, Zhang C, Luo X, Tsauo J, Tang C, Li X. Education andImaging. Hepatobiliary and pancreatic: hepatocellular carcinoma supplied byportal blood after repeated transcatheter arterial chemoembolization. JGastroenterol Hepatol 2012;27:1408.

51. Liu L, Yu Y, Jin X, WangZ, Li X. Management of superiormesenteric arteriovenous fistula after small bowel resection 20 yearspreviously: endovascular treatment. Can J Gastroenterol 2012;26:864-865.

52. Chen B, Tang CW, ZhangCL, Cao JW, Wei B, Li X.Melena-associated regional portal hypertension caused by splenic arteriovenousfistula. World J Gastroenterol 2012;18:1996-1998.

53. Tsauo J, Luo X, Ye L, Li X. Three-Dimensional Path PlanningSoftware-Assisted Transjugular Intrahepatic Portosystemic Shunt: A TechnicalModification. Cardiovasc Intervent Radiol. 2014 Jun 17. [Epub ahead of print]PMID: 24934737.

54. Yao D, Kunam VK, Li X.A review of the clinical diagnosis and therapy ofcholangiocarcinoma. J Int Med Res. 2014;42(1):3-16.

55. Yao D, Luo X, Zhou B, Li X. Ileal conduit stomalvariceal bleedingmanaged by endovascular embolization. World J Gastroenterol. 2013; 19(44):8156–8159.

56. Luo X, Nie L, Wang Z, Tsauo J, Tang C, Li X. Transjugular endovascularrecanalization of splenic vein in patients with regional portal hypertensioncomplicated by gastrointestinal bleeding. Cardiovasc Intervent Radiol. 2014Feb;37(1):108-13.

57. Tsauo J, Yang D, Ma H, Li X. Traumatic inferior gluteal arterypseudoaneurysm with compressive neuropathy managed with endovascular embolizationand surgery. Cardiovasc Intervent Radiol. 2014 Feb;37(1):275-7.

58. Li X, LiF, Wei B, Li B, Tang CW. Small-for-size syndrome after living donor livertransplantation: successful treatment with a transjugular intrahepaticportosystemic shunt. Liver Transpl 2012;18:1118-1120.

59. Liu L, Yu Y, Zhang C, Luo X, Tsauo J, Tang C, Li X. Education andImaging. Hepatobiliary and pancreatic: hepatocellular carcinoma supplied byportal blood after repeated transcatheter arterial chemoembolization. J Gastroenterol Hepatol.2012;27(8):1408.

60. Li X, Tang CW. An obscure mass in the head of the pancreas of anadolescent. Gut. 2011;60(8):1086, 1138.

61. LiX, Li HC, Tang CW. Endovascularembolization for gastrointestinal bleeding caused by splenic arteriovenousfistula. Chin Med J (Engl) 2010;123:2616-2618.

62. Li X, Zhou X, Guan Y, Wang YX, Scutt D, Gong QY.N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model:radiological and histopathological studies. Cardiovasc Intervent Radiol.2006;29(3):420-8.

63. Li X, Wang YX, Zhou X, Guan Y,Tang C. Catheterization of the hepatic artery via the left common carotidartery in rats. Cardiovasc Intervent Radiol. 2006;29(6):1073-6.

64. Li X,Zhou XP, Guan YS, Wang YX. Magnetic resonance imaging of hepatocellularcarcinoma induced by diethylnitrosamine in Sprague-Dawley rats. Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):427-32.